Yıl: 2007 Cilt: 18 Sayı: 2 Sayfa Aralığı: 89 - 94 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids

Öz:
Amaç: ‹nşamatuvar barsak hastalığı gibi hastalıklı kolon mukozası na kısa zincirli yağ asidi ve glutaminin etkileri tam olarak aydınlatılamamıştır. Bu çalışmanın amacı deneysel kolitte L-glutamin ve kısa zincirli yağ asidi kokteyli lavmanı ve oral uygulamalarının kolon mukozası iyileşmesine etkilerini incelemektir. Gereç ve yöntem: Çalışmada sıçanlarda etanol içinde trinitrobenzensülfonik asid lavmanı ile kolit oluşturuldu. Gruplar; Serum fizyolojik lavmanı (Kolit grubu, n: 12), L-glutamin lavmanı grubu (n: 12), kısa zincirli yağ asidi lavmanı grubu (n: 12), oral l-glutamin grubu (n: 11) ve oral kısa zincirli yağ asidi grubu (n: 11) şeklinde idi. Lavman solusyonu kolit oluşturulduktan sonra on gün süre ile günde iki kere uygulandı. Sham grubunda kolit oluşturulmadan sadece serum fizyolojik lavmanı uygulandı (n: 12). Onuncu gün sakrifiye edilen sı- çanlarda kolon mukozasındaki kript derinliği ve mukozal DNA içeriği ölçüldü. Bulgular: Kript derinliği her iki glutamin grubu ve kısa zincirli yağ asidi lavmanı gruplarında sham ve kolit gruplarından fazla bulundu (p < 0.05). Mukozal DNA içeriği kolit ve her iki glutamin gruplarında kısa zincirli yağ asidi gruplarına göre daha fazla idi (p < 0.05). Oral glutamin grubu mukozal DNA içeriği de kısa zincirli yağ asidi lavmanı grubundan daha fazla idi (p < 0.05). Sonuç: Sıçanlarda deneysel kolitte L-glutamin mukozal iyileşme ve regenerasyonunu hızlandı rabilmektedir. Kısa zincirli yağ asidi kokteyli ise bu çalışmada glutamin kadar etkili bulunmamıştır.
Anahtar Kelime: İlaç uygulama, oral Hastalık modelleri, hayvan Glutamin Yenilenme DNA Kolit Asitler, asiklik Bağırsak mukozası Yara iyileşmesi Sıçan, Wistar

Konular: Cerrahi

Deneysel kolitte L-glutamin’in mukozal iyileşmeye etkisi kısa-zincirli yağ asitlerinden üstündür

Öz:
Background/aims: The effects of short-chain fatty acids and glutamine on diseased colonic mucosa, such as in inflammatory bowel disease, are not well described. The aim of this study was to investigate the role of L-glutamine and short-chain fatty acids, both via enema and oral administration, on mucosal healing in experimental colitis. Methods: Colitis was induced with trinitrobenzenesulphonic acid in ethanol enema in rats. Saline enema (Colitis group, n: 12), L-glutamine enema (n: 12), short-chain fatty acids enema (n: 12), oral L-glutamine (n:11) and oral short-chain fatty acids (n.11) were applied twice daily for 10 days after induction of colitis. The sham group (n: 12) received only saline enema. Rats were sacrificed at the tenth day. Crypt depth and DNA content were measured in colonic mucosa. Results: Crypt depth was significantly greater in both glutamine groups and short-chain fatty acids enema group than in sham and colitis groups (p<0.05). The mucosal DNA contents of the colitis and glutamine enema groups were significantly greater than both short-chain fatty acids groups (p<0.05). DNA content in the oral glutamine group was significantly greater than in the short-chain fatty acids enema group (p<0.05). Conclusions: L-glutamine enema can accelerate mucosal healing and regeneration in experimentally induced colitis in rats. When compared to glutamine in this study, shortchain fatty acids showed no beneficial effect on colitis.
Anahtar Kelime: Colitis Acids, Acyclic Intestinal Mucosa Wound Healing Rats, Wistar Administration, Oral Disease Models, Animal Glutamine Regeneration DNA

Konular: Cerrahi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Simmonds NJ, Rampton OS. Inflammatory bowel disease - a radical view. Gut 1993; 34: 865-8.
  • 2. Roediger WEW. The colonic epithelium in ulcerative colitis: an energy deficiency disease? Lancet 1980; 4: 712-5.
  • 3. Evans MA, Shronts EP. Intestinal fuels. Glutamine, short chain-fatty acids, and dietary fiber. J Am Diet Assoc 1992; 92: 1239-46.
  • 4. Rombeau JL, Kripke SA. Metabolic and intestinal effects of short-chain fatty acids. JPEN 1990; 14: 181-5.
  • 5. Mortensen FV, Hessov I, Birke H, et al. Microcirculatory and trophic effects of short chain fatty acids in the human rectum after Hartman’s procedure. Br J Surg 1991; 78: 1208-11.
  • 6. Friedel D, Levine GM. Effect of short-chain fatty acids on colonic function and structure. JPEN 1992; 16: 1-4.
  • 7. Ruppin H, Bar-Meir S, Soergel KH, et al. Absorption of short-chain fatty acid by the colon. Gastroenterology 1980; 78: 1500-7.
  • 8. Steinhart AH, Brezinski A, Baker JP. Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol 1994; 89: 179-83.
  • 9. Scheppach W, Sommer H, Kirchner T, et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992; 103: 51-6.
  • 10. Senagore AJ, MacKeigan JM, Scheider M, Ebrom JS. Short-chain fatty acid enemas: a cost effective alternative in the treatment of nonspecific proctosigmoiditis. Dis Colon Rectum 1992; 35: 923-7.
  • 11. Verria P, Montelenen G, Grandinetti G, et al. Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: a randomized, double-blinded, placebo-controlled pilot study. Dig Dis Sci 2000; 45: 976- 81.
  • 12. Breuer RI, Soergel KH, Lashner BA, et al. Short chain fatty acid rectal irrigation for left–sided ulcerative colitis: a randomized placebo controlled trial. Gut 1997; 40: 485-91.
  • 13. Wachtershauser A, Stein J. Rationale for luminal provision of butyrate in intestinal disease. Eur J Nutr 2000; 39: 164- 71.
  • 14. Mandir N, Goodlad RA. The effects of glutamine on intestinal epithelial cell proliferation in parenterally fed rats. Gut 1999; 44: 608-14.
  • 15. Fujita T, Sakurai K. Efficacy of glutamine-enriched enteral nutrition in an experimental model of mucosal ulcerative colitis. Br J Surg 1995; 82: 749-51.
  • 16. Ameho CK, Adjei AA, Harrison EK, et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor a production in trinitrobenzene sulphonic acid induced colitis. Gut 1997; 41: 487-93.
  • 17. Kaya E, Gür ES, Özgüç H, et al. L-glutamine enemas attenuate mucosal injury in experimental colitis. Dis Colon Rectum 1999; 42: 1209-15.
  • 18.Hogan B, Constantine F, Lacy E. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1986; 174-6.
  • 19. Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795-803.
  • 20. Kruschewski M, Foitzik T, Perez-Canto A, et al. Changes of colonic mucosal microcirculation and histology in two colitis models: an experimental study using intravital microscopy and a new histological scoring system. Dig Dis Sci 2001; 46: 2336-43.
  • 21. Vilaseca J, Salas A, Guarner F, et al. Dietary fish oil reduces progression of chronic inflammatory lesions in rat model of granulomatous colitis. Gut 1990; 31: 539-44.
  • 22. Gardiner KR, Anderson NH, Rowlands BJ, et al. Colitis and colonic mucosal barrier dysfunction. Gut 1995; 37: 530-5.
  • 23. Frankel WL, Zhang W, Singh A, et al. Mediation of the trophic effect of short-chain fatty acids on the rat jejunum and colon. Gastroenterology 1994; 106: 375-80.
  • 24. Schmitt NG Jr, Soergel KH, Wood JM. Absorption of shortchain fatty acids from human jejunum. Gastroenterology 1976; 70: 211-5.
  • 25. Schmitt NG Jr, Soergel KH, Wood JM, et al. Absorption of short-chain fatty acids from human ileum. Am J Dig Dis 1977; 22: 340-7.
  • 26. Breuer RI, Buto SK, Christ ML, et al. Rectal irrigation with short-chain fatty acids for distal ulcerative colitis. Dig Dis Sci 1991; 36: 185-7.
  • 27. Roediger WEW, Nance S. Metabolic induction of experimental ulcerative colitis by inhibition of fatty oxidation. Br J Exp Pathol 1986; 67: 773-82.
  • 28. Scheppach W, Bartram P, Richter A, et al. Effect of shortchain fatty acids on the human colonic mucosa in vitro. JPEN 1992; 16: 43-8.
  • 29. Finnie IA, Dwarakanath AD, Taylor BA, et al. Colonic mucin synthesis is increased by sodium butyrate. Gut 1995; 36: 93-9.
  • 30. Chapman MA, Grahn MF, Boyle MA, et al. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 1994; 35: 73-6.
  • 31. Araki Y, Andoh A, Tsujikawa T, et al. Alterations in intestinal microflora, fecal bile acids and short chain fatty acids in dextran sulphate sodium-induced experimental acute colitis in rats. Eur J Gastroenterol Hepatol 2001; 13: 107-12.
  • 32. Chapman MA, Grahn MF, Hutton M, et al. Butyrate metabolism in the terminal ileal mucosa of patients with ulcerative colitis. Br J Surg 1995; 82: 36-8.
  • 33. Binder HJ, Mehta P. Characterization of butyrate-dependent electroneutral Na-Cl absorption in the rat distal colon. Pfulugers Archl 1990; 417: 365-9.
  • 34. Cummings JH. Short chain fatty acids in the human colon.Gut 1981; 22: 763-79.
  • 35. Tarrerias AL, Millecamps M, Alloui A, et al. Short-chain fatty acid enemas fail to decrease colonic hypersensitivity and inflammation in TNBS-induced colonic inflammation in rats. Pain 2002; 100: 91-7.
  • 36. Ko TC, Beauchamp D, Townsend CM, et al. Glutamine is essential for epidermal growth factor-stimulated intestinal cell proliferation. Surgery 1993; 114: 147-54.
  • 37. Fabia R, Willen R, Ar’Rajab A, et al. Acetic acid-induced colitis in the rat: a reproducible experimental model for acute ulcerative colitis. Eur Surg Res 1992; 24: 211-25.
  • 38. Hartmann F, Plauth M. Intestinal glutamine metabolism. Metabolism 1989; 38: 18-24.
  • 39. Heys SD, Ashkanani F. Glutamine. Br J Surg 1999; 86: 289-90.
  • 40. Finnie IA, Taylor BA, Rhodes JM. Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism. Gut 1993; 34: 1552-8.
  • 41. Krauseselt AI, Fürst P. Glutamine (GLN) supplementation promotes glutathione (GSH) synthesis and prevents intestinal ischemia/reperfusion (I/R) injury. Clin Nutrition 2001; 20: 59-60.
  • 42.Humbert B, Nguyem P, Martin L, et al. Use of stable isotopes to assess gut glutathione metabolism in vivo in dogs: effect of glutamine. Clin Nutrition 2001; 20: 59-60.
  • 43. den Hond E, Hiele M, Peeters M, et al. Effect of long-term glutamine supplements on small intestinal permeability in patients with Crohn’s disease. JPEN 1999; 23(1): 7-11.
  • 44. Arndt H, Kullmann F, Reuss F, et al. Glutamine attenuates leukocyte - endothelial cell adhesion in indomethacininduced intestinal inflammation in the rat. JPEN 1999; 23: 12-8.
APA KAYA E, CEYLAN A, KARA N, GÜVEN H, YILDIZ L (2007). The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids. , 89 - 94.
Chicago KAYA Ekrem,CEYLAN ALPER,KARA Nurettin,GÜVEN Hakan,YILDIZ Levent The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids. (2007): 89 - 94.
MLA KAYA Ekrem,CEYLAN ALPER,KARA Nurettin,GÜVEN Hakan,YILDIZ Levent The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids. , 2007, ss.89 - 94.
AMA KAYA E,CEYLAN A,KARA N,GÜVEN H,YILDIZ L The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids. . 2007; 89 - 94.
Vancouver KAYA E,CEYLAN A,KARA N,GÜVEN H,YILDIZ L The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids. . 2007; 89 - 94.
IEEE KAYA E,CEYLAN A,KARA N,GÜVEN H,YILDIZ L "The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids." , ss.89 - 94, 2007.
ISNAD KAYA, Ekrem vd. "The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids". (2007), 89-94.
APA KAYA E, CEYLAN A, KARA N, GÜVEN H, YILDIZ L (2007). The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids. Turkish Journal of Gastroenterology, 18(2), 89 - 94.
Chicago KAYA Ekrem,CEYLAN ALPER,KARA Nurettin,GÜVEN Hakan,YILDIZ Levent The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids. Turkish Journal of Gastroenterology 18, no.2 (2007): 89 - 94.
MLA KAYA Ekrem,CEYLAN ALPER,KARA Nurettin,GÜVEN Hakan,YILDIZ Levent The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids. Turkish Journal of Gastroenterology, vol.18, no.2, 2007, ss.89 - 94.
AMA KAYA E,CEYLAN A,KARA N,GÜVEN H,YILDIZ L The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids. Turkish Journal of Gastroenterology. 2007; 18(2): 89 - 94.
Vancouver KAYA E,CEYLAN A,KARA N,GÜVEN H,YILDIZ L The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids. Turkish Journal of Gastroenterology. 2007; 18(2): 89 - 94.
IEEE KAYA E,CEYLAN A,KARA N,GÜVEN H,YILDIZ L "The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids." Turkish Journal of Gastroenterology, 18, ss.89 - 94, 2007.
ISNAD KAYA, Ekrem vd. "The effect of L-glutamine on mucosal healing in experimental colitis is superior to short-chain fatty acids". Turkish Journal of Gastroenterology 18/2 (2007), 89-94.